Global Scopolamine Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Scopolamine Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Scopolamine Market Size Growth Rate by Type
  • 1.4.2 Scopolamine Butylbromide
  • 1.4.3 Scopolamine Hydrobromide
  • 1.2.4 Scopolamine Base
• 1.3 Market by Application
  • 1.3.1 Global Scopolamine Market Size Growth Rate by Application
  • 1.3.2 Oral
  • 1.3.3 Injection
  • 1.3.4 Patches
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Scopolamine Sales Estimates and Forecasts 2016-2027
• 2.2 Global Scopolamine Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Scopolamine Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Scopolamine Regions by Sales
  • 2.4.1 Global Top Scopolamine Regions by Sales (2016-2021)
  • 2.4.2 Global Top Scopolamine Regions by Sales (2022-2027)
• 2.5 Global Top Scopolamine Regions by Revenue
  • 2.5.1 Global Top Scopolamine Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Scopolamine Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Scopolamine Sales by Manufacturers
  • 3.1.1 Global Top Scopolamine Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Scopolamine Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Scopolamine Sales in 2020
• 3.2 Global Scopolamine Revenue by Manufacturers
  • 3.2.1 Global Top Scopolamine Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Scopolamine Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Scopolamine Revenue in 2020
• 3.3 Global Scopolamine Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Scopolamine Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Scopolamine Sales by Type
  • 4.1.1 Global Scopolamine Historical Sales by Type (2016-2021)
  • 4.1.2 Global Scopolamine Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Scopolamine Sales Market Share by Type (2016-2027)
• 4.2 Global Scopolamine Revenue by Type
  • 4.2.1 Global Scopolamine Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Scopolamine Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Scopolamine Revenue Market Share by Type (2016-2027)
• 4.3 Global Scopolamine Price by Type
  • 4.3.1 Global Scopolamine Price by Type (2016-2021)
  • 4.3.2 Global Scopolamine Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Scopolamine Sales by Application
  • 5.1.1 Global Scopolamine Historical Sales by Application (2016-2021)
  • 5.1.2 Global Scopolamine Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Scopolamine Sales Market Share by Application (2016-2027)
• 5.2 Global Scopolamine Revenue by Application
  • 5.2.1 Global Scopolamine Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Scopolamine Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Scopolamine Revenue Market Share by Application (2016-2027)
• 5.3 Global Scopolamine Price by Application
  • 5.3.1 Global Scopolamine Price by Application (2016-2021)
  • 5.3.2 Global Scopolamine Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Scopolamine Market Size by Type
  • 6.1.1 North America Scopolamine Sales by Type (2016-2027)
  • 6.1.2 North America Scopolamine Revenue by Type (2016-2027)
• 6.2 North America Scopolamine Market Size by Application
  • 6.2.1 North America Scopolamine Sales by Application (2016-2027)
  • 6.2.2 North America Scopolamine Revenue by Application (2016-2027)
• 6.3 North America Scopolamine Market Size by Country
  • 6.3.1 North America Scopolamine Sales by Country (2016-2027)
  • 6.3.2 North America Scopolamine Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Scopolamine Market Size by Type
  • 7.1.1 Europe Scopolamine Sales by Type (2017-2027)
  • 7.1.2 Europe Scopolamine Revenue by Type (2017-2027)
• 7.2 Europe Scopolamine Market Size by Application
  • 7.2.1 Europe Scopolamine Sales by Application (2017-2027)
  • 7.2.2 Europe Scopolamine Revenue by Application (2017-2027)
• 7.3 Europe Scopolamine Market Size by Country
  • 7.3.1 Europe Scopolamine Sales by Country (2017-2027)
  • 7.3.2 Europe Scopolamine Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Scopolamine Market Size by Type
  • 8.1.1 Asia Pacific Scopolamine Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Scopolamine Revenue by Type (2018-2027)
• 8.2 Asia Pacific Scopolamine Market Size by Application
  • 8.2.1 Asia Pacific Scopolamine Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Scopolamine Revenue by Application (2018-2027)
• 8.3 Asia Pacific Scopolamine Market Size by Region
  • 8.3.1 Asia Pacific Scopolamine Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Scopolamine Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Scopolamine Market Size by Type
  • 9.1.1 Latin America Scopolamine Sales by Type (2019-2027)
  • 9.1.2 Latin America Scopolamine Revenue by Type (2019-2027)
• 9.2 Latin America Scopolamine Market Size by Application
  • 9.2.1 Latin America Scopolamine Sales by Application (2019-2027)
  • 9.2.2 Latin America Scopolamine Revenue by Application (2019-2027)
• 9.3 Latin America Scopolamine Market Size by Country
  • 9.3.1 Latin America Scopolamine Sales by Country (2019-2027)
  • 9.3.2 Latin America Scopolamine Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Scopolamine Market Size by Type
  • 6.1.1 Middle East and Africa Scopolamine Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Scopolamine Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Scopolamine Market Size by Application
  • 6.2.1 Middle East and Africa Scopolamine Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Scopolamine Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Scopolamine Market Size by Country
  • 6.3.1 Middle East and Africa Scopolamine Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Scopolamine Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Alkaloids of Australia
  • 11.1.1 Alkaloids of Australia Corporation Information
  • 11.1.2 Alkaloids of Australia Overview
  • 11.1.3 Alkaloids of Australia Scopolamine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Alkaloids of Australia Scopolamine Product Description
  • 11.1.5 Alkaloids of Australia Related Developments
• 11.2 Boehringer Ingelheim
  • 11.2.1 Boehringer Ingelheim Corporation Information
  • 11.2.2 Boehringer Ingelheim Overview
  • 11.2.3 Boehringer Ingelheim Scopolamine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Boehringer Ingelheim Scopolamine Product Description
  • 11.2.5 Boehringer Ingelheim Related Developments
• 11.3 Fine Chemicals Corporation
  • 11.3.1 Fine Chemicals Corporation Corporation Information
  • 11.3.2 Fine Chemicals Corporation Overview
  • 11.3.3 Fine Chemicals Corporation Scopolamine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Fine Chemicals Corporation Scopolamine Product Description
  • 11.3.5 Fine Chemicals Corporation Related Developments
• 11.4 Phytex Australia
  • 11.4.1 Phytex Australia Corporation Information
  • 11.4.2 Phytex Australia Overview
  • 11.4.3 Phytex Australia Scopolamine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Phytex Australia Scopolamine Product Description
  • 11.4.5 Phytex Australia Related Developments
• 11.5 Alchem International
  • 11.5.1 Alchem International Corporation Information
  • 11.5.2 Alchem International Overview
  • 11.5.3 Alchem International Scopolamine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Alchem International Scopolamine Product Description
  • 11.5.5 Alchem International Related Developments
• 11.6 Guangzhou Hanfang
  • 11.6.1 Guangzhou Hanfang Corporation Information
  • 11.6.2 Guangzhou Hanfang Overview
  • 11.6.3 Guangzhou Hanfang Scopolamine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Guangzhou Hanfang Scopolamine Product Description
  • 11.6.5 Guangzhou Hanfang Related Developments
• 11.7 Alkaloids Corporation
  • 11.7.1 Alkaloids Corporation Corporation Information
  • 11.7.2 Alkaloids Corporation Overview
  • 11.7.3 Alkaloids Corporation Scopolamine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Alkaloids Corporation Scopolamine Product Description
  • 11.7.5 Alkaloids Corporation Related Developments
• 11.8 Luyin
  • 11.8.1 Luyin Corporation Information
  • 11.8.2 Luyin Overview
  • 11.8.3 Luyin Scopolamine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Luyin Scopolamine Product Description
  • 11.8.5 Luyin Related Developments
• 11.1 Alkaloids of Australia
  • 11.1.1 Alkaloids of Australia Corporation Information
  • 11.1.2 Alkaloids of Australia Overview
  • 11.1.3 Alkaloids of Australia Scopolamine Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Alkaloids of Australia Scopolamine Product Description
  • 11.1.5 Alkaloids of Australia Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Scopolamine Value Chain Analysis
• 12.2 Scopolamine Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Scopolamine Production Mode & Process
• 12.4 Scopolamine Sales and Marketing
  • 12.4.1 Scopolamine Sales Channels
  • 12.4.2 Scopolamine Distributors
• 12.5 Scopolamine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Scopolamine Industry Trends
• 13.2 Scopolamine Market Drivers
• 13.3 Scopolamine Market Challenges
• 13.4 Scopolamine Market Restraints

14 Key Findings in The Global Scopolamine Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details